SCHEMBL3388682

SCHEMBL3388682

CCC1(C)CC(=NO)C(C)C(C)(CC)N1O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26354407 0.84 MAPT (0.32) MAPT
SCHEMBL24468051 0.83
SCHEMBL14530671 0.80 MAPT (0.30) MAPT
SCHEMBL265093 0.77
SCHEMBL886988 0.70 CHRNA7 (0.32) MAPT
SCHEMBL2135049 0.70 CHRNA7 (0.32) MAPT
SCHEMBL7071595 0.67 KDM4E (0.34)
SCHEMBL12059923 0.67
SCHEMBL26075029 0.65 KDM4E (0.31) MAPT
SCHEMBL18901133 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397349-B1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS BASF SE (DE) 2010-12-15 EP disclosed
US-7199245-B2 Polymerizable olefin composition with imino alkoxyalkylpiperidine for controlling polymerization and free radical catalyst CIBA SPECIALTY CHEMICALS CORP. (US) 2007-04-03 US disclosed
US-20040176553-A1 4-Imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators CIBA SPECIALTY CHEMICALS CORP. 2004-09-09 US disclosed
EP-1397349-A1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS Ciba SC Holding AG (CH) 2004-03-17 EP disclosed
WO-2002100831-A1 4-IMINO-N-ALKOXY OR OXY-POLYALKYL-PIPERIDINE COMPOUNDS AND THEIR USE AS POLYMERIZATION REGULATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176553-A1 4-Imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators PTGER4, PNMT, OPRM1 MAPT 4276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.